Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared a post on LinkedIn:
”I am excited to invite you to our 2026 State of the Organization, a virtual presentation where I’ll share our vision and priorities at The Max Foundation.
In the year ahead, we are deepening our commitment to what matters most: developing a strategy to more than double our impact by reaching 100,000 patients annually by 2031. This is the driving force behind every partnership we build and every innovation we pursue.
During the presentation, I’ll discuss four organizational priorities for the year and what they mean in real world practice. In 2026, we’re building on that foundation and reaching farther than ever before.
I hope you’ll join me to hear more about how, together, we can continue advancing health equity around the world.
Date: February 19, 2026, 8:00 AM PT
Let’s make this a year of bold impact—one patient, one partnership, one breakthrough at a time.”
Stay updated with Hemostasis Today.
-
Feb 11, 2026, 17:00A Major Step Forward for the Global Bleeding Disorders Community – Haemophilia Foundation Australia
-
Feb 11, 2026, 16:47Pall T. Onundarson and Mandeep Mehra on Diverse Approaches to Anticoagulation in LVAD Patients
-
Feb 11, 2026, 16:37Rahul Gosain: Are Cancer Outcomes Directly Related to Lymphocyte Counts?
-
Feb 11, 2026, 16:35Are DOACs Actually Safer in Advanced Cirrhosis – RPTH Journal
-
Feb 11, 2026, 16:33Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
-
Feb 11, 2026, 16:20Ney Carter Borges։ Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
-
Feb 11, 2026, 16:18The Hidden Risks of Blood Thinners and the Need for Safer Anticoagulants – National Blood Clot Alliance
-
Feb 11, 2026, 16:13Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis
-
Feb 11, 2026, 16:12Annabel Hölzle Takes Runner-Up Award in Basic Science and Translational Research at ESC Heart and Stroke 2025